Paul King

CFO

Paul started 30 years ago as a Series 3 trader. He followed that by starting and taking his biomed portfolio to over $1.2 billion valuation

About

Paul King

Paul started his career almost 30 years ago as a Series 3 trader. He followed that by starting and taking his biomed portfolio from a $6 million valuation to over $1.2 billion. Paul has managed large asset classes in several countries and is an expert at defining and managing risk while delivering consistent growth.

Past experience